126 related articles for article (PubMed ID: 38884619)
1. Integration of a Community Opioid Treatment Program into a Federally Qualified Health Center.
Neeb C; McQuade BM; Lesondak L; Madrid S; Schlaeger JM; Watson DP; Karnik N; Huerta N; Bhatia S; Fleurimont J; Li N; Hammerdahl E; Pesantez R; Gastala N
J Addict Med; 2024 Jun; ():. PubMed ID: 38884619
[TBL] [Abstract][Full Text] [Related]
2. Methadone Treatment Gap in Tennessee and How Medication Units Could Bridge the Gap: A Review.
Risby J; Schlesinger E; Geminn W; Cernasev A
Pharmacy (Basel); 2023 Aug; 11(5):. PubMed ID: 37736904
[TBL] [Abstract][Full Text] [Related]
3. Expanding access to methadone treatment in Ohio through federally qualified health centers and a chain pharmacy: A geospatial modeling analysis.
Iloglu S; Joudrey PJ; Wang EA; Thornhill TA; Gonsalves G
Drug Alcohol Depend; 2021 Mar; 220():108534. PubMed ID: 33497963
[TBL] [Abstract][Full Text] [Related]
4. Health care use and spending for Medicaid patients diagnosed with opioid use disorder receiving primary care in Federally Qualified Health Centers and other primary care settings.
Peterson L; Murugesan M; Nocon R; Hoang H; Bolton J; Laiteerapong N; Pollack H; Marsh J
PLoS One; 2022; 17(10):e0276066. PubMed ID: 36256662
[TBL] [Abstract][Full Text] [Related]
5. Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability.
Brooner RK; Stoller KB; Patel P; Wu LT; Yan H; Kidorf M
Drug Alcohol Depend Rep; 2022 Jun; 3():. PubMed ID: 35757566
[TBL] [Abstract][Full Text] [Related]
6. Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study.
Dickerson SS; George SJ; Ventuneac A; Dharia A; Talal AH
J Med Internet Res; 2024 Jun; 26():e53049. PubMed ID: 38865703
[TBL] [Abstract][Full Text] [Related]
7. In-Hospital Methadone Enrollment: a Novel Program to Facilitate Linkage from the Hospital to the Opioid Treatment Program for Vulnerable Patients with Opioid Use Disorder.
Calcaterra SL; Saunders S; Grimm E; Maki-Gianani E; Keniston A; Wold A; Bonaguidi A
J Gen Intern Med; 2024 Feb; 39(3):385-392. PubMed ID: 37715094
[TBL] [Abstract][Full Text] [Related]
8. Bridge clinic implementation of "72-hour rule" methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in care.
Taylor JL; Laks J; Christine PJ; Kehoe J; Evans J; Kim TW; Farrell NM; White CS; Weinstein ZM; Walley AY
Drug Alcohol Depend; 2022 Jul; 236():109497. PubMed ID: 35607834
[TBL] [Abstract][Full Text] [Related]
9. Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.
Wu LT; John WS; Morse ED; Adkins S; Pippin J; Brooner RK; Schwartz RP
Addiction; 2022 Feb; 117(2):444-456. PubMed ID: 34286886
[TBL] [Abstract][Full Text] [Related]
10. Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule.
Laks J; Kehoe J; Farrell NM; Komaromy M; Kolodziej J; Walley AY; Taylor JL
Addict Sci Clin Pract; 2021 Dec; 16(1):73. PubMed ID: 34961554
[TBL] [Abstract][Full Text] [Related]
11. Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff.
Wu LT; Mannelli P; John WS; Anderson A; Schwartz RP
Subst Abuse Treat Prev Policy; 2023 Sep; 18(1):55. PubMed ID: 37697326
[TBL] [Abstract][Full Text] [Related]
12. Access to methadone clinics and opioid overdose deaths in Georgia: A geospatial analysis.
Anwar T; Duever M; Jayawardhana J
Drug Alcohol Depend; 2022 Sep; 238():109565. PubMed ID: 35839618
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and current clinical practices of opioid treatment programs in the United States.
Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
[TBL] [Abstract][Full Text] [Related]
14. Adapting methadone inductions to the fentanyl era.
Buresh M; Nahvi S; Steiger S; Weinstein ZM
J Subst Abuse Treat; 2022 Oct; 141():108832. PubMed ID: 35870437
[TBL] [Abstract][Full Text] [Related]
15. Introduction of Medicare coverage in opioid treatment programs: Findings from the first three years.
Abraham AJ; Harris SJ; Yarbrough CR
J Subst Use Addict Treat; 2024 Mar; 158():209247. PubMed ID: 38072386
[TBL] [Abstract][Full Text] [Related]
16. Opioid treatment program culture and philosophy: Views of OTP staff and state officials on implementing interim methadone treatment.
Burruss-Cousins K; Mitchell SG; Gryczynski J; Whitter M; Fuller D; Ibrahim A; Schwartz RP
J Subst Use Addict Treat; 2024 Feb; 157():209265. PubMed ID: 38103832
[TBL] [Abstract][Full Text] [Related]
17. Federally Qualified Health Centers Can Expand Rural Access to Buprenorphine for Opioid Use Disorder in Arizona.
Brady BR; Gildersleeve R; Koch BD; Campos-Outcalt DE; Derksen DJ
Health Serv Insights; 2021; 14():11786329211037502. PubMed ID: 34408434
[TBL] [Abstract][Full Text] [Related]
18. Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic.
López-Castro T; Jakubowski A; Masyukova M; Peterson M; Pierz A; Kodali S; Arnsten JH; Starrels JL; Nahvi S
J Subst Use Addict Treat; 2024 Feb; 157():209235. PubMed ID: 38061636
[TBL] [Abstract][Full Text] [Related]
19. "Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment.
Suen LW; Steiger S; Shapiro B; Castellanos S; Joshi N; Lambdin BH; Knight KR
Int J Drug Policy; 2023 Nov; 121():104214. PubMed ID: 37778132
[TBL] [Abstract][Full Text] [Related]
20. Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis.
Levander XA; Hoffman KA; McIlveen JW; McCarty D; Terashima JP; Korthuis PT
Addict Sci Clin Pract; 2021 Dec; 16(1):72. PubMed ID: 34895346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
